These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24381107)

  • 1. Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.
    Cha Z; Zang Y; Guo H; Gu H; Tu X; Song H; Qian B
    Mol Biol Rep; 2014 Feb; 41(2):1165-70. PubMed ID: 24381107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.
    Gao L; Feng Z; Li Q; Li L; Chen L; Xiao T
    Tumour Biol; 2014 Apr; 35(4):2997-3002. PubMed ID: 24248544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study.
    Zhu Q; Liu T
    Mol Biol Rep; 2012 Sep; 39(9):8679-85. PubMed ID: 22696188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between fibroblast growth factor receptor 4 Gly388Arg polymorphism and ischaemic stroke.
    Zhang HF; Zhao KJ; Yang PF; Fang YB; Zhang YH; Liu JM; Huang QH
    J Int Med Res; 2012; 40(5):1708-14. PubMed ID: 23206452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease.
    Ma L; Zhang H; Han C; Tong D; Zhang M; Yao Y; Luo Y; Liu X
    DNA Cell Biol; 2012 Jun; 31(6):1064-9. PubMed ID: 22313031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension.
    Al-Daghri NM; Mohammed AK; Al-Attas OS; Draz HM; Alokail MS
    Genet Test Mol Biomarkers; 2017 Jul; 21(7):422-427. PubMed ID: 28650667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.
    Shen YY; Lu YC; Shen DP; Liu YJ; Su XY; Zhu GS; Yin XL; Ni XZ
    World J Gastroenterol; 2013 Jul; 19(28):4568-75. PubMed ID: 23901234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGFR4 genetic polymorphisms determine the chemotherapy response of Chinese patients with non-small cell lung cancer.
    Fang HM; Tian G; Zhou LJ; Zhou HY; Fang YZ
    Acta Pharmacol Sin; 2013 Apr; 34(4):549-54. PubMed ID: 23524567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
    Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH
    Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
    Song H; Tong D; Cha Z; Bai J
    Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
    Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
    Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of fibroblast growth factor receptor 4 polymorphisms in the susceptibility and clinical features of ischemic stroke.
    Yin C; Li S; Zhao W; Guo Y; Zhang Y; Feng J
    J Clin Neurosci; 2014 Feb; 21(2):246-9. PubMed ID: 24239227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
    Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
    Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.
    Jiang Y; Sun S; Wei W; Ren Y; Liu J; Pang D
    Oncotarget; 2015 Oct; 6(32):34023-9. PubMed ID: 26431494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.
    Moazeni-Roodi A; Sarabandi S; Karami S; Hashemi M; Ghavami S
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33017009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor receptor 4 Gly388Arg polymorphism associated with severity of gallstone disease in a Chinese population.
    Chen Q; Li WJ; Wan YY; Yu CD; Li WG
    Genet Mol Res; 2012 Mar; 11(1):548-55. PubMed ID: 22535390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
    Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
    Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
    Sheu MJ; Hsieh MJ; Chiang WL; Yang SF; Lee HL; Lee LM; Yeh CB
    PLoS One; 2015; 10(4):e0122961. PubMed ID: 25860955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
    Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T
    Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
    Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
    Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.